Ehud Rechtman
Overview
Explore the profile of Ehud Rechtman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
273
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gepstein R, Rosman Y, Rechtman E, Koren-Morag N, Segev S, Assia E, et al.
Blood Press
. 2012 Jan;
21(3):191-6.
PMID: 22263560
Background: The most common ophthalmologic manifestation of hypertension is hypertensive retinopathy. Our study was designed to evaluate the factors that determine retinal vessel caliber in hypertensive subjects. Methods: During a...
2.
Rechtman E, Stalmans I, Glovinsky J, Breusegem C, Moisseiev J, Van Calster J, et al.
Clin Ophthalmol
. 2011 Mar;
5:37-44.
PMID: 21386919
Purpose: To evaluate the effect of intravitreal (IVT) bevacizumab in neovascular age-related macular degeneration (AMD) on global choroidal hemodynamics, as measured by ocular pulse amplitude (OPA). Methods: This was a...
3.
Fabian I, Barequet I, Skaat A, Rechtman E, Goldenfeld M, Roberts C, et al.
Am J Ophthalmol
. 2011 Feb;
151(5):774-81.
PMID: 21310386
Purpose: To compare intraocular pressure (IOP) measurements obtained using the Goldmann applanation tonometer (GAT; Haag-Streit), the Tono-Pen XL (Reichert, Inc), and the ocular response analyzer (ORA; Reichert Ophthalmic Instruments), and...
4.
Skaat A, Solomon A, Moroz I, Hai O, Rechtman E, Vishnevskia Dai V, et al.
Acta Ophthalmol
. 2010 Oct;
89(3):e269-73.
PMID: 20946333
Purpose: To assess the effect of bevacizumab (Avastin), a vascular endothelial growth factor inhibitor, on retinal function by full-field electroretinography (ERG) in patients with neovascular age-related macular degeneration (AMD). Design:...
5.
Rechtman E, Harris A, Garzozi H, Ciulla T
Clin Ophthalmol
. 2009 Aug;
1(4):383-91.
PMID: 19668515
Diabetic retinopathy (DR) and diabetic macular edema (DME) are leading causes of blindness in the working-aged population of most developed countries. The increasing number of persons with diabetes worldwide suggests...
6.
Ben-Zion I, Harris A, Weizman Y, Ehrlich R, Rechtman E
Harefuah
. 2008 Dec;
147(10):812-7, 836.
PMID: 19039914
The concept of retinal oximetry is based on physical properties that have been recognized since the 18th century. Attempts to non-invasively quantify the oxygen saturation of blood within the retinal...
7.
Sines D, Kagemann L, Siesky B, Rechtman E, Garzozi H, Harris A
Ophthalmic Surg Lasers Imaging
. 2008 Jun;
39(3):203-8.
PMID: 18556940
Background And Objective: To evaluate the difference in arteriovenous passage time calculated from retinal angiograms using indocyanine green and fluorescein sodium dye in healthy individuals. Patients And Methods: Examinations of...
8.
Rechtman E, Harris A
Clin Exp Ophthalmol
. 2008 Mar;
36(2):111-2.
PMID: 18352865
No abstract available.
9.
Harris A, Garzozi H, McCranor L, Rechtman E, Yung C, Siesky B
Int Ophthalmol
. 2008 Feb;
29(1):19-26.
PMID: 18297248
Purpose: To investigate the effect of latanoprost on ocular hemodynamics in healthy subjects. Methods: In a randomized, double-masked, placebo-controlled crossover study, 12 healthy subjects received either placebo or latanoprost for...
10.
Rechtman E, Harris A
Harefuah
. 2007 Dec;
146(11):872-7, 909.
PMID: 18087835
Diabetic retinopathy is the most common microvascular complication of diabetes mellitus. Research performed over the last several decades has demonstrated the benefit of systemic control and ocular treatments in reducing...